The tranSMART Foundation attended the BioIT World 2016 Conference in Boston MA. The Conference took place between April 4th and 7th, 2016 at the World Trade Center across from the Seaport Hotel in Boston.
tranSMART Foundation Events
Tuesday April 5th, 2016
→ 3C Committee Meetings
The tranSMART Foundation 3C Committees will be meeting the afternoon of Tuesday April 5th from 2:30 to 5:30PM at the Mass Board Room, Exchange Conference Center, Boston Fish Pier, 212 Northern Ave, Boston.
2:30 to 3:30 – Community Committee – Co-chairs – Keith Nangle (Foundation) and Sherry Cao (Sanofi)
3:30 to 4:30 – Content Committee – Co-charis – Rudy Potenzone (Foundation) and Julie Bryant (Rancho)
4:30 to 5:30 – Code Committee – John O-Hara (Foundation) and Jay Bergeron (Pfizer)
Wednesday April 6th, 2016
→ BioIT World 2016 Presentations
Track 5 – Bioinformatics: Computational Resources and Tools to Turn Big Data into Smart Data
11:30 eTRIKS and tranSMART in IMI’s PreDiCT-TB: Data Management, Modeling and Comparison
Francisco Bonachela Capdevila, Ph.D., Postdoc Data Coordinator, Translational Informatics and External Innovation, Janssen Pharmaceutica
PreDiCT-TB is an IMI-funded project which takes a comprehensive model-based approach to fill the gaps in the current drug development pathway in tuberculosis. Preclinical information is propagated into the clinical stage in order to optimize drug selection at the clinical phase. In this context, we have developed a tranSMART-based solution that extracts PK-PD modeling data from studies at any in vitro, in vivo or clinical stage of the drug development chain. This allows the ranking of drug regimens to be compared across preclinical and clinical studies. This ranking comparison will provide us with an informed framework for the translatability of drug regimens data during the clinical phase.
1:55 From Phenotype to Genotype: Using TranSMART for Managing Human Genetics Data
Andrew Hill, Science and Technology Lead, Research Business Technology, Pfizer
Genotype/phenotype analysis informs target identification, validation, mechanistic understanding, and precision medicine. Genetic variants and associated phenotype datasets are large, complex, and difficult to manage and access. The bioinformatics community needs to share information about both challenges and solutions. In this presentation we’ll describe our experience with using TranSMART as a repository for human genotype-phenotype data.
Track 7 – Clinical Research & Translational Informatics; Transforming Biological Data to Clinical Development
11:30 Establishing, Improving and Sustaining Primary and Secondary Clinical Exploratory Research Pipelines
Jay Bergeron, Director, Translational and Bioinformatics, Pfizer
1:10 Luncheon Presentation II: Accelerating Insights in Translational Research: Self-Service Analytics and Visualizations at Amgen
George Seegan, Ph.D., Research & Development Informatics, Amgen
David Hardison, Ph.D., Vice President, Health Sciences, ConvergeHEALTH by Deloitte
tranSMART Community Meeting co-hosted with Thomson Reuters and the Pistoia Alliance
with tranSMART 2016 Corporate Sponsors GeneDx and Rancho BioSciences
5:45 – 8:00 PM at the Seaport Hotel Ballroom
Opening – Rudy Potenzone, VP Marketing, tranSMART Foundation
Welcome and Thomson Reuters Update – Chris McKenna
Welcome and Update on the Pistoia Alliance – Carmen Nitsche
Welcome and Update on the tranSMART Foundation – Keith Elliston, CEO, tranSMART Foundation
Introduction of the tranSMART Foundation Corporate Sponsors \
We want to thank our Corporate Sponsors for their generous support of the Foundation
2016 PLATINUM CORPORATE SPONSORS